TORII PHARMACEUTICAL CO., LTD.
4551 | T
Overview
Corporate Details
- ISIN(s):
- N/A
- LEI:
- Country:
- Japan
- Address:
- 中央区日本橋本町三丁目４番１号
- Website:
- https://www.torii.co.jp/en/
- Sector:
- Health Care
- Industry:
- Pharmaceuticals
Description
Torii Pharmaceutical Co., Ltd. is a prominent Japanese pharmaceutical company dedicated to the development, manufacturing, and marketing of innovative healthcare solutions. Established with a commitment to improving patient lives, Torii focuses on a diverse range of therapeutic areas, including oncology, immunology, and infectious diseases. The company prides itself on its strong research and development capabilities, striving to bring new treatments to market that meet the evolving needs of healthcare providers and patients. With a vision to enhance global health, Torii collaborates with various partners in the pharmaceutical industry, fostering innovation and ensuring the highest standards of quality in its products.
Market Data
Market Data Not Available
Financials & KPIs
No Financial Data Available
Standardized financial statements for the selected period are not yet available.
Filings
| Date | Filing | Language | Size | Actions |
|---|---|---|---|---|
| 2025-07-10 08:30 |
Inside Information Statement
臨時報告書
|
Japanese | 215.5 KB | |
| 2025-06-19 02:04 |
Inside Information Statement
臨時報告書
|
Japanese | 23.2 KB | |
| 2025-06-04 09:05 |
Regulatory News Service
訂正意見表明報告書
|
Japanese | 171.8 KB | |
| 2025-05-08 08:56 |
Regulatory News Service
意見表明報告書
|
Japanese | 373.9 KB | |
| 2025-03-31 08:30 |
Inside Information Statement
臨時報告書
|
Japanese | 24.8 KB | |
| 2025-03-27 07:23 |
Internal Control over Financial Reporting
内部統制報告書－第133期(2024/01/01－2024/12/31)
|
Japanese | 24.0 KB | |
| 2025-03-27 07:22 |
Regulatory News Service
確認書
|
Japanese | 9.3 KB | |
| 2025-03-27 07:18 |
Annual Report
有価証券報告書－第133期(2024/01/01－2024/12/31)
|
Japanese | 1.0 MB | |
| 2024-08-01 03:06 |
Regulatory News Service
確認書
|
Japanese | 9.2 KB | |
| 2024-08-01 03:05 |
Interim Report
半期報告書－第133期(2024/01/01－2024/12/31)
|
Japanese | 187.0 KB | |
| 2024-04-26 08:07 |
Regulatory News Service
確認書
|
Japanese | 9.2 KB | |
| 2024-04-26 08:06 |
Quarterly Report
四半期報告書－第133期第1四半期(2024/01/01－2024/03/31)
|
Japanese | 143.5 KB | |
| 2024-03-29 07:17 |
Inside Information Statement
臨時報告書
|
Japanese | 39.3 KB | |
| 2024-03-27 07:11 |
Internal Control over Financial Reporting
内部統制報告書－第132期(2023/01/01－2023/12/31)
|
Japanese | 24.0 KB | |
| 2024-03-27 07:10 |
Regulatory News Service
確認書
|
Japanese | 9.3 KB |
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
| Company | Country | Ticker | View | |
|---|---|---|---|---|
|
Antibiotice S.A. | Romania | ATB | |
|
Aran Research & Development (1982) Ltd. | Israel | ARAN | |
|
Asarina Pharma AB | Sweden | ASAP | |
| ASKA Pharmaceutical Holdings CO., Ltd. | Japan | 4886 | ||
|
Astellas Pharma Inc. | Japan | 4503 | |
|
AstraZeneca PLC | United Kingdom | AZN | |
|
Basilea Pharmaceutica AG | Switzerland | BSLN | |
|
Bayer AG | Germany | BAY | |
|
Biofarm S.A. | Romania | BIO | |
|
Biogened Spolka Akcyjna | Poland | BGD |